Cunha Mariana Faucz Munhoz da, Sevignani Gabriela, Pavanelli Giovana Memari, Carvalho Mauricio de, Barreto Fellype Carvalho
Universidade Federal do Paraná, Departamento de Pediatria, Serviço de Nefrologia Pediátrica, Curitiba, PR, Brasil.
Hospital Pequeno Príncipe, Serviço de Nefrologia Pediátrica, Curitiba, PR, Brasil.
J Bras Nefrol. 2020 Mar 20;42(2):219-230. doi: 10.1590/2175-8239-JBN-2018-0217.
There are more than 150 different rare genetic kidney diseases. They can be classified according to diagnostic findings as (i) disorders of growth and structure, (ii) glomerular diseases, (iii) tubular, and (iv) metabolic diseases. In recent years, there has been a shift of paradigm in this field. Molecular testing has become more accessible, our understanding of the underlying pathophysiologic mechanisms of these diseases has evolved, and new therapeutic strategies have become more available. Therefore, the role of nephrologists has progressively shifted from a mere spectator to an active player, part of a multidisciplinary team in the diagnosis and treatment of these disorders. This article provides an overview of the recent advances in rare hereditary kidney disorders by discussing the genetic aspects, clinical manifestations, diagnostic, and therapeutic approaches of some of these disorders, named familial focal and segmental glomerulosclerosis, tuberous sclerosis complex, Fabry nephropathy, and MYH-9 related disorder.
有150多种不同的罕见遗传性肾病。它们可根据诊断结果分为:(i)生长和结构障碍;(ii)肾小球疾病;(iii)肾小管疾病;(iv)代谢性疾病。近年来,该领域出现了范式转变。分子检测变得更加容易获得,我们对这些疾病潜在病理生理机制的理解不断发展,新的治疗策略也越来越多。因此,肾病学家的角色已逐渐从单纯的旁观者转变为积极参与者,成为诊断和治疗这些疾病的多学科团队的一部分。本文通过讨论其中一些疾病,即家族性局灶节段性肾小球硬化、结节性硬化症、法布里肾病和MYH-9相关疾病的遗传方面、临床表现、诊断和治疗方法,概述了罕见遗传性肾病的最新进展。